No Prescription |
 |
 | ||
|
Cilamin Cuprimine |
|
| ||
No Prescription » Prescription Drugs 4 » Cilamin Cuprimine This medication is used to treat rheumatoid arthritis and Wilson's disease (high levels of copper in the body that can result in damage to the liver and other organs). It is also used to prevent kidney stones. Penicillamine belongs to a class of drugs known as disease-modifying anti-rheumatoid drugs (DMARDs) and chelating agents.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This drug may also be used to treat lead poisoning certain liver conditions and certain skin conditions.How to use Penicillamine OralTake this medication by mouth without food on an empty stomach (1 hour before or 2 hours after meals) 1 to 4 times daily or as directed by your doctor. Take each dose with a full glass of water (8 ounces or 240 milliliters). Avoid taking any other medication food or milk within at least 1 hour of taking penicillamine. Iron can interfere with the absorption of this medication. If you take supplements containing iron take them at least 2 hours apart from your dose of this medication. Take the last dose at least 3 hours after the evening meal.Drink plenty of water while taking this medication unless your doctor directs you otherwise.Dosage is based on your medical condition and response to treatment.Use this medication regularly to get the most benefit from it. To help you remember take it at the same time(s) each day.What conditions does this medication treat?Penicillamine Oral is used to treat the following:Excessive Urinary Excretion of the Amino Acid Cystine Excessive Copper Deposits in the Liver and Brain Kidney Stones caused by Cystine Rheumatoid ArthritisPenicillamine Oral may also be used to treat:Inflammation of Blood Vessels with Rheumatoid Arthritis Arthritis with Enlarged Spleen and Low White Blood Cell Count Poisoning by Heavy Metals Buy Cilamin Cuprimine and other Prescription Drugs 4 products online at Medstore. Buy Online at Medstore - Click Here!
About Cilamin Cuprimine: Product Type: Prescription Drugs 4 Cilamin ( Cuprimine Generic Penicillamine ) Cilamin (Cuprimine Generic Penicillamine) Cuprimine Generic Penicillamine 250 MG 50 Capsules 200(4 x 50) Capsules 100(2 x 50) Capsules Cuprimine Generic Penicillamine Cilamin
View more Prescription Drugs 4 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
